Product Information

GABAPENTIN 400 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0400 per EA under NDC 65162010350. Its NADAC has been published 626 times since Aug 27, 2014.

FDA first approved this application on Jul 25, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 400 MG CAPSULE

Gabapentin
$0.0400per EA

Strength

400 mg/1

NDC

65162010350

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA078428

FDA Approved

7/25/2007

TE Code

AB

On Market Since

11/24/2009

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 400 MG CAPSULE has been published 626 times since Aug 27, 2014, and over the history we have for it it has declined 54.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0400 per EA
All-time high$0.0883 (Sep 10, 2014)
All-time low$0.0396 (Apr 22, 2026)
52-week high$0.0445
52-week low$0.0396
Median price$0.0646
Average price$0.0627
Largest weekly change+23.4% (Aug 21, 2024)
Weeks tracked626
Tracking sinceAug 27, 2014

Price History

1W

-1.6%

1M

-2.6%

3M

-1.7%

6M

-1.5%

1Y

-10.2%

3Y

-28.2%

5Y

-36.3%

All

-54.7%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN 400 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Amneal Pharmaceuticals LLC, is $0.0400 per EA (NDC 65162010350), effective Aug 19, 2026.

How has the price of GABAPENTIN 400 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 54.7%. It has been tracked across 626 weekly CMS publications since Aug 27, 2014.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?

Since Aug 27, 2014, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.0883 (Sep 10, 2014), with a median of $0.0646 per EA.

Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?

15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 400 MG CAPSULE?

GABAPENTIN 400 MG CAPSULE (NDC 65162010350) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.